Next report date
Report period
Q1 2024
EPS estimate
−0.44USD
Revenue estimate
—
−2.52USD
−77.39 MUSD
22.25 M
About Reneo Pharmaceuticals, Inc.
Sector
Industry
CEO
Gregory J. Flesher
Website
Headquarters
Irvine
Employees (FY)
8
Founded
2014
FIGI
BBG00JVRSRC1
Reneo Pharmaceuticals, Inc. is a clinical-stage company, which engages in the research and development of therapies for rare genetic mitochondrial diseases. The company was founded by Michael G. Grey and Niall O'Donnell on September 22, 2014 and is headquartered in San Diego, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of RPHM is 1.68 USD — it has increased by 0.30% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Reneo Pharmaceuticals, Inc. stocks are traded under the ticker RPHM.
Reneo Pharmaceuticals, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
RPHM stock is 2.41% volatile and has beta coefficient of −1.44. Check out the list of the most volatile stocks — is Reneo Pharmaceuticals, Inc. there?
RPHM earnings for the last quarter are −0.57 USD per share, whereas the estimation was −0.57 USD resulting in a 0.25% surprise. The estimated earnings for the next quarter are −0.58 USD per share. See more details about Reneo Pharmaceuticals, Inc. earnings.
Yes, you can track Reneo Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
RPHM stock has risen by 2.44% compared to the previous week, the month change is a 3.07% rise, over the last year Reneo Pharmaceuticals, Inc. has showed a 82.43% decrease.
RPHM net income for the last quarter is −23.55 M USD, while the quarter before that showed −19.20 M USD of net income which accounts for −22.70% change. Track more Reneo Pharmaceuticals, Inc. financial stats to get the full picture.
Today Reneo Pharmaceuticals, Inc. has the market capitalization of 56.15 M, it has increased by 2.42% over the last week.
No, RPHM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RPHM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Reneo Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 8.00 employees. See our rating of the largest employees — is Reneo Pharmaceuticals, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Reneo Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Reneo Pharmaceuticals, Inc. stock shows the sell signal. See more of Reneo Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Reneo Pharmaceuticals, Inc. future price: according to them, RPHM price has a max estimate of 1.20 USD and a min estimate of 1.00 USD. Read a more detailed Reneo Pharmaceuticals, Inc. forecast: see what analysts think of Reneo Pharmaceuticals, Inc. and suggest that you do with its stocks.